Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immunotherapy-Induced Auto-Splenectomy in a Patient of Malignant Melanoma.
Journal: Cureus
Published: May 16, 2022
Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity.
Journal: Cancer immunology research
Published: April 29, 2020
Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.
Journal: Journal for immunotherapy of cancer
Published: October 31, 2018
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: April 11, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.
Journal: Clinical genitourinary cancer
Published: March 25, 2016
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: February 09, 2016
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.
Journal: Bone marrow transplantation
Published: February 09, 2016
Lichenoid reaction as a potential immune response marker of intratreatment histological response during successful vismodegib treatment for a giant basal cell carcinoma.
Journal: Dermatologic therapy
Published: June 27, 2015
High-Dose Interleukin-2 (HD IL-2) Therapy Should Be Considered for Treatment of Patients with Melanoma Brain Metastases.
Journal: Chemotherapy research and practice
Published: February 26, 2013
Coexistent metastatic melanoma of the kidney with unknown primary and renal cell carcinoma.
Journal: BMJ case reports
Published: December 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026